Search Results - Shuhei Mayanagi
- Showing 1 - 5 results of 5
-
1
-
2
Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer by Shuhei Mayanagi, Yasuhiro Tsubosa, Katsuhiro Omae, Masahiro Niihara, Tsuneyuki Uchida, Takahiro Tsushima, Tomoya Yokota, Hiroshi Sato, Tateaki Naito, Hirofumi Yasui
Published 2017Artigo -
3
Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients’ data from three large phase III randomized trials by Toru Aoyama, Koji Oba, Michitaka Honda, Sotaro Sadahiro, Chikuma Hamada, Shuhei Mayanagi, Mitsuro Kanda, Hiromichi Maeda, Kosuke Kashiwabara, Junichi Sakamoto, Shigetoyo Saji, Takaki Yoshikawa
Published 2017Artigo -
4
Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer by Shuhei Mayanagi, Kosuke Kashiwabara, Michitaka Honda, Koji Oba, Toru Aoyama, Mitsuro Kanda, Hiromichi Maeda, Chikuma Hamada, Sotaro Sadahiro, Junichi Sakamoto, Shigetoyo Saji, Takaki Yoshikawa
Published 2018Artigo -
5
Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer by Shuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, Tatsuo Matsuda, Tomonobu Fujita, Hajime Higuchi, Junichi Taguchi, Hiroya Takeuchi, Osamu Itano, Koichi Aiura, Yasuo Hamamoto, Hiromasa Takaishi, Masato Okamoto, Makoto Sunamura, Yutaka Kawakami, Yuko Kitagawa
Published 2015Artigo
Search Tools:
Related Subjects
Cancer
Internal medicine
Medicine
Oncology
Surgery
Chemotherapy
Biology
Breast cancer
Colorectal cancer
Esophageal cancer
Esophagectomy
Gastroenterology
Lymphadenectomy
Neoadjuvant therapy
Paleontology
Stage (stratigraphy)
Surgical oncology
Adjuvant
Adjuvant therapy
Carboplatin
Chemoradiotherapy
Cisplatin
Clinical trial
Confidence interval
Docetaxel
Gemcitabine
Hazard ratio
Immune system
Immunology
Immunotherapy